Effectiveness and Safety of Adding Bevacizumab to Platinum-Based Chemotherapy as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis

Background and Objective: Previous studies have evaluated the efficacy (OS, overall survival; PFS, progression-free survival; ORR, objective response rate) and adverse events of bevacizumab combined with platinum-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer (NSCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Li, Hui-Min, Wang, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277997/
https://www.ncbi.nlm.nih.gov/pubmed/34277647
http://dx.doi.org/10.3389/fmed.2021.616380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277997/
https://www.ncbi.nlm.nih.gov/pubmed/34277647
http://dx.doi.org/10.3389/fmed.2021.616380

Ejemplares similares